Pri-Med Podcasts

Overview: Coadministration of drugs should be done with caution, because drug-drug interactions can cause serious adverse effects. Being cognizant of relevant pharmacodynamics, pharmacokinetics, and pharmacogenetics aspects of a variety of drugs, including analgesics, can reduce such effects. Guest: Oscar A. De Leon-Casasola, MD

Overview: Join pulmonologist Dr. Chris Fanta as he discusses acute exacerbations and COPD. The podcast begins with a typical case presentation seen in primary care which highlights the experience of acute exacerbations of COPD. Next, Dr. Fanta discusses the impact of COPD on the lives of patients and, lastly, discusses how COPD is treatable and, to some extent, preventable in an outpatient setting. Please note that any data, indications, and guidelines presented in this activity are current as of the recording 9/1/2020 and they are subject to change as new information is published.  Guest: Christopher H. Fanta, MD

Overview: Join cardiologist Ty Gluckman, MD in part one of this two part podcast series as he reviews the latest guideline-based management of heart failure with reduced ejection fraction (HFrEF), bringing to light major advances in the past years and evidence supporting these advances.     Guest: Ty Gluckman, MD

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-190
Overview: A review of the latest evidence on antibody testing to identify current and past COVID-19 infection
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™ Claim CME/CE credit: https://pri-med.com/online-education/podcast/cme-podcast-influenza-genentech-1-pt1 Overview: In the first episode of this 3-part mini-series on influenza, infectious disease specialist, Daniel Solomon M.D., reviews the epidemiology of flu and discusses the importance of prevention and diagnosis during the current COVID-19 pandemic. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 8/26/2020 and they are subject to change as new information is published.

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-189
Overview: This session will discuss an observational study performed in Denmark on how receiving the influenza vaccine affected diabetics long-term outcomes.
Guest: Jill Terrien, PhD, ANP-BC  
Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-188
Overview: A review of the latest evidence regarding hydroxychloroquine (HCQ) as treatment for SARS-CoV-2 infection.
Guest: Alan Ehrlich, MD
 

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-187
Overview: This podcast will review what is known and theorized about vitamin D status, susceptibility to viral infections, and mortality from viral infections.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-186
Overview: This episode will review current literature on COVID-19 data.
Guest: Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/rems-podcast-4-nsaids-8-20  Overview: Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for pain management in a variety of settings and for a variety of conditions. This podcast summarizes the evidence for efficacy as well as for toxicities associated with this drug class and outlines current guideline recommendations. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Guest: Oscar A. De Leon-Casasola, MD